Pharmacoeconomic analyses make way into oncology

被引：1
|
作者：
Amber, D
机构：
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2000年 / 92卷 / 15期
关键词：
D O I：
10.1093/jnci/92.15.1204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1204 / 1205
页数：2
相关论文
共 50 条
  • [1] Problems in pharmacoeconomic analyses - Reply
    Rennie, D
    Luft, HS
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (15): : 1924 - 1924
  • [2] Use of pharmacoeconomic messages in oncology promotional
    Kalpas, E.
    Subrahmanian, T.
    Stern, L.
    VALUE IN HEALTH, 2008, 11 (03) : A80 - A81
  • [3] Pharmacoeconomic issues in head and neck oncology
    de Souza, Jonas A.
    Lopes, Gilberto de Lima
    Cohen, Ezra E. W.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (03) : 213 - 217
  • [4] Do Pharmacoeconomic Analyses Impact Price Negotiation Outcomes in Canada? Comparison of Rare Disease and Oncology Drugs
    Privolnev, Y.
    Liovas, A.
    Jakac-Sinclair, N.
    VALUE IN HEALTH, 2022, 25 (12) : S336 - S336
  • [5] How to improve your pharmacoeconomic analyses with sensitivity analyses
    Basskin, L
    FORMULARY, 1997, 32 (08) : 842 - &
  • [6] Methodological hurdles in conducting pharmacoeconomic analyses
    Rizzo, JD
    Powe, NR
    PHARMACOECONOMICS, 1999, 15 (04) : 339 - 355
  • [7] Published pharmacoeconomic analyses: science or marketing?
    Henry, D
    Lang, D
    INTERNAL MEDICINE JOURNAL, 2003, 33 (9-10) : 403 - 404
  • [8] Common errors and controversies in pharmacoeconomic analyses
    Byford, S
    Palmer, S
    PHARMACOECONOMICS, 1998, 13 (06) : 659 - 666
  • [9] Common errors and controversies in pharmacoeconomic analyses
    Soto, J
    PHARMACOECONOMICS, 1998, 14 (06) : 711 - 712
  • [10] Methodological hurdles in conducting pharmacoeconomic analyses
    Rizzo J.D.
    Powe N.R.
    PharmacoEconomics, 1999, 15 (4) : 339 - 355
12345